Discontinued — last reported Q4 '25
UnitedHealth Group Acquisitions decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $702.00M to $0.00. Over 4 years (FY 2021 to FY 2025), Acquisitions shows relatively stable performance with a -1.7% CAGR.
High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.
This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...
Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.
acquisitions| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.45B | $85.00M | $94.00M | $1.23B | $5.92B | $4.00M | $14.30B | $7.83B | $335.00M | $228.00M | $1.75B | $3.01B | $25.00M | $8.64B | $1.73B | $702.00M | $32.00M | $3.70B | $73.00M | $0.00 |
| QoQ Change | — | -97.5% | +10.6% | >999% | +380.8% | -99.9% | >999% | -45.3% | -95.7% | -31.9% | +666.2% | +72.1% | -99.2% | >999% | -79.9% | -59.5% | -95.4% | >999% | -98.0% | -100.0% |
| YoY Change | — | — | — | — | +71.6% | -95.3% | >999% | +535.7% | -94.3% | >999% | -87.8% | -61.6% | -92.5% | >999% | -0.7% | -76.6% | +28.0% | -57.2% | -95.8% | -100.0% |